Advanced Oxygen Technologies, Inc. is a U.S.-based medical technology company focused on the development, manufacture and distribution of oxygen delivery and related therapeutic devices. Through its wholly owned subsidiary OxySure Systems, AOXY designs portable, on-demand oxygen generation units that provide respiratory support without the need for pressurized cylinders. These systems are primarily used by first responders, home healthcare providers and industrial safety teams, offering lightweight, user-friendly solutions for emergency and routine oxygen therapy.
The company was originally founded as Lang Pharmaceuticals Nutrition and, following a strategic pivot, rebranded to Advanced Oxygen Technologies in early 2021. This transformation was driven by the acquisition of OxySure Systems’ proprietary technology, which shifted AOXY’s emphasis toward point-of-use oxygen generation. Since the acquisition, AOXY has invested in product refinements, regulatory clearances and scaled manufacturing capabilities to support broader market adoption.
AOXY’s products are marketed across North America and are gradually being introduced into Latin American and European markets through distribution partnerships. The company’s go-to-market strategy involves collaborations with emergency medical service providers, equipment dealers in the home healthcare channel and select industrial distributors. AOXY continues to explore additional applications for its oxygen generation technology, including maritime safety and remote-site operations.
Headquartered in Orlando, Florida, Advanced Oxygen Technologies is led by President and Chief Executive Officer Michael Krepps, who brings over 25 years of experience in medical device commercialization. The executive team also includes Chief Financial Officer Anna Smith and Chief Operating Officer David Johnson, each of whom has played a key role in scaling production, navigating regulatory pathways and guiding the company’s international expansion.
AI Generated. May Contain Errors.
